Elexacaftor
Back to searchScientific Name: | Elexacaftor |
Brand Name: | Trikafta (100 Mg / 50 Mg / 75 Mg; 150 Mg) |
Company Owner: | Not Available |
Mechanism Of Action | Cystic fibrosis (CF) is the result of a mutation in the cystic fibrosis transmembrane conductance regulator (CFTR) gene. |
Description of the Drug: | Elexacaftor is a small molecule CFTR corrector used in combination with tezacaftor and ivacaftor for the treatment of cystic fibrosis patients with one F508del-CFTR mutation. |
Protein Data Bank: |
Source: DrugBank Online – DrugBank.com. Retrieved 2023-01-23 from https://go.drugbank.com/drugs/DB15444